Oppenheimer & Co’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.54M | Buy |
42,079
+1,488
| +4% | +$197K | 0.07% | 307 |
|
|
2025
Q4 | $5.76M | Sell |
40,591
-432
| -1% | -$62.6K | 0.08% | 275 |
|
|
2025
Q3 | $5.76M | Buy |
41,023
+625
| +2% | +$84.7K | 0.07% | 309 |
|
|
2025
Q2 | $5.08M | Buy |
40,398
+21,010
| +108% | +$2.41M | 0.07% | 315 |
|
|
2025
Q1 | $2.14M | Buy |
19,388
+447
| +2% | +$56.6K | 0.03% | 523 |
|
|
2024
Q4 | $2.59M | Sell |
18,941
-348
| -2% | -$43K | 0.04% | 480 |
|
|
2024
Q3 | $2.22M | Buy |
19,289
+2,051
| +12% | +$281K | 0.03% | 516 |
|
|
2024
Q2 | $2.37M | Buy |
17,238
+283
| +2% | +$38.8K | 0.04% | 473 |
|
|
2024
Q1 | $2.34M | Sell |
16,955
-214
| -1% | -$29.2K | 0.04% | 468 |
|
|
2023
Q4 | $2.26M | Buy |
17,169
+249
| +1% | +$28.7K | 0.04% | 462 |
|
|
2023
Q3 | $1.9M | Buy |
16,920
+437
| +3% | +$46K | 0.04% | 479 |
|
|
2023
Q2 | $1.55M | Buy |
16,483
+25
| +0.2% | +$2.44K | 0.03% | 544 |
|
|
2023
Q1 | $1.67M | Sell |
16,458
-3,539
| -18% | -$368K | 0.04% | 502 |
|
|
2022
Q4 | $2.39M | Buy |
19,997
+1,473
| +8% | +$173K | 0.05% | 393 |
|
|
2022
Q3 | $1.97M | Buy |
18,524
+6,257
| +51% | +$635K | 0.05% | 433 |
|
|
2022
Q2 | $1.2M | Buy |
12,267
+145
| +1% | +$13.4K | 0.03% | 623 |
|
|
2022
Q1 | $1.14M | Sell |
12,122
-164
| -1% | -$13.9K | 0.02% | 698 |
|
|
2021
Q4 | $1.05M | Buy |
12,286
+6,423
| +110% | +$591K | 0.02% | 761 |
|
|
2021
Q3 | $562K | Buy |
5,863
+183
| +3% | +$17.3K | 0.01% | 969 |
|
|
2021
Q2 | $553K | Buy |
5,680
+1,781
| +46% | +$171K | 0.01% | 983 |
|
|
2021
Q1 | $379K | Sell |
3,899
-16
| -0.4% | -$1.68K | 0.01% | 1085 |
|
|
2020
Q4 | $375K | Buy |
3,915
+128
| +3% | +$12.4K | 0.01% | 1001 |
|
|
2020
Q3 | $364K | Buy |
3,787
+768
| +25% | +$88.8K | 0.01% | 915 |
|
|
2020
Q2 | $369K | Sell |
3,019
-284
| -9% | -$31.4K | 0.01% | 899 |
|
|
2020
Q1 | $286K | Sell |
3,303
-3,264
| -50% | -$319K | 0.01% | 914 |
|
|
2019
Q4 | $706K | Buy |
6,567
+603
| +10% | +$63.1K | 0.02% | 727 |
|
|
2019
Q3 | $537K | Buy |
5,964
+3,270
| +121% | +$306K | 0.01% | 770 |
|
|
2019
Q2 | $227K | Sell |
2,694
-4,195
| -61% | -$344K | 0.01% | 1129 |
|
|
2019
Q1 | $607K | Buy |
6,889
+1,773
| +35% | +$148K | 0.02% | 737 |
|
|
2018
Q4 | $365K | Sell |
5,116
-1,329
| -21% | -$127K | 0.01% | 857 |
|
|
2018
Q3 | $792K | Buy |
6,445
+3,068
| +91% | +$348K | 0.02% | 676 |
|
|
2018
Q2 | $332K | Sell |
3,377
-159
| -4% | -$14.2K | 0.01% | 1018 |
|
|
2018
Q1 | $293K | Buy |
+3,536
| New | +$299K | 0.01% | 1073 |
|
|
2014
Q1 | – | Sell |
-13,200
| Closed | -$124K | – | 1448 |
|
|
2013
Q4 | $124K | Buy |
+13,200
| New | +$129K | ﹤0.01% | 1295 |
|
Other funds holding NBIX
VPM
VCM
